Abstract Advances in the care of patients with prostate cancer across the disease spectrum have resulted in substantial survival gains over recent decades. However, global disparities in prostate cancer survival, stage at diagnosis, and access to timely diagnosis and treatment remain among the greatest across all malignancies. We aimed to quantify country-level health system correlates of the prostate cancer mortality-to-incidence ratio (MIR).
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Jonas Willmann
Beyond borders: advancing oncology trials
A recent British Journal of Cancer study by Anderson et al. comparing real-world NHS England outcomes for abemaciclib plus fulvestrant against the pivotal MONARCH-2 trial found a median overall survival gap of nearly 21 months that could not be explained by differences in age, gender, or performance status, a reminder that pivotal trial evidence sometimes fails to generalise to real-world populations [1].
Metastatic Trajectories in Non–Small Cell Lung Cancer Guide Local and Systemic Therapies
Advances in systemic therapy have improved outcomes for metastatic non–small cell lung cancer (NSCLC), yet resistance and progression remain nearly universal. Local therapies such as radiotherapy, surgery, and image-guided ablation can extend disease control in selected patients, but existing classifications—including dynamic models of oligometastatic disease—assign a single state per patient and do not capture lesion-level heterogeneity.
Cervical cancer screening beyond traditional barriers
The PREVENT Project implementation study, published in the Lancet Public Health by Aime Powell and colleagues, showed success in cervical cancer screening for Aboriginal and Torres Strait Islander women in Western Australia.1 The study's achievement of 36% participation rates and 95% same-day colposcopy completion among women who tested positive for human papillomavirus represents a major advance in addressing screening disparities that affect marginalised populations globally.
Reirradiation: Standards, challenges, and patient‐focused strategies across tumor types
GENERAL INTRODUCTION TO REIRRADIATION Radiation therapy (RT) is a cornerstone in the treatment of a majority of cancers, whereby high-energy radiation is administered to eradicate cancer cells while minimizing collateral damage to surrounding healthy tissues.
Stereotactic Body Radiotherapy Without Systemic Therapy for Oligometastatic Cancer
Stereotactic Body Radiotherapy Without Systemic Therapy for Oligometastatic Cancer: A Systematic Review and Meta-Analysis Supplement 1. eMethods 1. Study Design and Data Management eMethods 2. Interpretation of I2 Statistic for Heterogeneity Assessment, Following Cochrane Handbook Guidelines eFigure.
Cancers | Free Full-Text | Oncological Outcomes, Long-Term Toxicities, Quality of Life and Sexual Health after Pencil-Beam Scanning Proton Therapy in Patients with Low-Grade Glioma
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Deep-Learning-Based Dose Predictor for Glioblastoma-Assessing the Sensitivity and Robustness for Dose Awareness in Contouring
4. Discussion By means of an existing dose prediction model that was trained for head and neck cases, we obtained good results for translating the dose prediction model to glioblastoma cases in the brain. For these initial results, only 60 cases were used for training. Compared to the results of the OpenKBP challenge, using their proposed metrics, our initial trained model scored better values than the top ranked participants did.
European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making
Definition of re-irradiation After baseline assessment by the Delphi consensus panellists, 14 potential defining characteristics of re-irradiation were collated and grouped into four categories (irradiated region, prescription dose, time interval between treatments, and degree of overlap of radiotherapy between treatments; appendix p 35).
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Jonas
Contact Jonas, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack